cagrilintide semaglutide dosage Three new #obesity drugs—high-dose semaglutide, plus cagrilintide, and oral orforglipron—may soon be approved in the US. JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin examine how Cagrilintide Dosing, Need to Know

The pipeline confirms the company is not standing still: the REDEFINE 1 Phase 3 trial of CagriSema a fixed-ratio combination of semaglutide and the amylin analogue cagrilintide demonstrated 22.7% weight loss at 68 weeks, superior to semaglutide alone

Third-Party Peptide Testing: Preference for pharmacies providing HPLC purity and endotoxin testing results per batch

Policy Option 9: States could align their Medicaid annual open enrollment period with the Medicare open enrollment period to encourage selection of integrated or aligned Medicare and Medicaid health plans

Persson AK, Thun J, Xu XJ, Wiesenfeld-Hallin Z, Strm M, Devor M, et al